[HTML][HTML] An update on inhibitors targeting RNA-dependent RNA polymerase for COVID-19 treatment: promises and challenges

X Xu, Y Chen, X Lu, W Zhang, W Fang, L Yuan… - Biochemical …, 2022 - Elsevier
The highly transmissible variants of SARS-CoV-2, the causative pathogen of the COVID-19
pandemic, bring new waves of infection worldwide. Identification of effective therapeutic …

RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic

L Tian, T Qiang, C Liang, X Ren, M Jia, J Zhang… - European journal of …, 2021 - Elsevier
The widespread nature of several viruses is greatly credited to their rapidly altering RNA
genomes that enable the infection to persist despite challenges presented by host cells …

RNA-dependent RNA polymerase as a target for COVID-19 drug discovery

W Zhu, CZ Chen, K Gorshkov, M Xu… - … the Science of Drug …, 2020 - journals.sagepub.com
COVID-19 respiratory disease caused by the severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2) has rapidly become a global health issue since it emerged in December …

The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2

Z Jin, H Wang, Y Duan, H Yang - Biochemical and Biophysical Research …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), poses an unprecedented global health …

[HTML][HTML] A cell-based assay to discover inhibitors of SARS-CoV-2 RNA dependent RNA polymerase

J Zhao, SS Guo, D Yi, Q Li, L Ma, Y Zhang, J Wang… - Antiviral research, 2021 - Elsevier
Antiviral therapeutics is one effective avenue to control and end this devastating COVID-19
pandemic. The viral RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 has been …

[HTML][HTML] Identifying small-molecule inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase by establishing a fluorometric assay

X Bai, H Sun, S Wu, Y Li, L Wang, B Hong - Frontiers in Immunology, 2022 - frontiersin.org
SARS-CoV-2 (severe acute respiratory syndrome coronavirus‐2), a member of the
coronavirus family, appeared in 2019 and has caused the largest global public health and …

Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses

R Kumar, S Mishra, SK Maurya - RSC Medicinal Chemistry, 2021 - pubs.rsc.org
WHO has declared COVID-19 a pandemic, which has affected the whole world and has
caused unprecedented social and economic disruption. Since the emergence of the …

[HTML][HTML] Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors

N Brindani, F Munafò, A Menichetti, E Donati… - Bioorganic & Medicinal …, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic. The identification of effective antiviral drugs remains an urgent …

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

I Vicenti, M Zazzi, F Saladini - Expert Opinion on Therapeutic …, 2021 - Taylor & Francis
ABSTRACT Introduction: The current SARS-CoV-2 pandemic urgently demands for both
prevention and treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has …

Structure-based drug design of RdRp inhibitors against SARS-CoV-2

K Shehzadi, A Saba, M Yu, J Liang - Topics in Current Chemistry, 2023 - Springer
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
worldwide pandemic since 2019, spreading rapidly and posing a significant threat to human …